MedTrace Logo

Genetic Risks for Childhood Cancer Complications in Switzerland

NCT04702321 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2021-01-13

No results posted yet for this study

Summary

The objectives of the GECCOS project are to identify genetic variants associated with complications of childhood cancer using genotype-phenotype association studies. Germline genetic samples and data of the "Germline DNA Biobank for Childhood Cancer and Blood Disorders Switzerland" (BISKIDS) which is included in the Geneva Biobank for Hematology and Oncology in Pediatrics (BaHOP) will be used with clinical data of Swiss childhood cancer patients collected at the Institute of Social and Preventive Medicine in Bern.

Conditions

  • Childhood Cancer
  • Genetic Predisposition
  • Late Effect

Interventions

OTHER

Procedure: Biospecimen Collection

Collection of saliva, buccal swabs, blood, or other sample adequate for germline DNA extraction

OTHER

Procedure: Medical Chart Review

Collection of clinical data

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2037-12-31
Completion
2037-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04702321 on ClinicalTrials.gov